Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243951
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaLiver Neoplasms
Shanghai Zhongshan Hospital 75
Not applicableEnded earlyNCT01305239
What this trial is testing

A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients

Who this might be right for
Breast Cancer
Pfizer 398
Testing effectiveness (Phase 2)Study completedNCT01106898
What this trial is testing

Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery

Who this might be right for
Stage IA Breast CancerStage IB Breast CancerStage IIA Breast Cancer+1 more
University of Nebraska 112
Testing effectiveness (Phase 2)Ended earlyNCT04421456
What this trial is testing

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Who this might be right for
Schizophrenia
Jazz Pharmaceuticals 95
Large-scale testing (Phase 3)Study completedNCT00744731
What this trial is testing

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 403
Large-scale testing (Phase 3)Ended earlyNCT00360412
What this trial is testing

E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Who this might be right for
Parkinson's Disease
Eisai Inc. 997
Not applicableUnknownNCT05845164
What this trial is testing

TDCS and Impulsivity

Who this might be right for
Substance Use DisordersSubstance AbuseSubstance Use
University of Arizona 30
Not applicableLooking for participantsNCT06106477
What this trial is testing

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 20
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Very early researchStudy completedNCT03395028
What this trial is testing

GCSF Adjunct Therapy for Biliary Atresia

Who this might be right for
Biliary Atresia
Holterman, Ai-Xuan, M.D. 6
Large-scale testing (Phase 3)Looking for participantsNCT05314998
What this trial is testing

Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature

Who this might be right for
Pancreatic Ductal Adenocarcinoma
John Neoptolemos 394
Post-approval studies (Phase 4)Looking for participantsNCT06368063
What this trial is testing

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Xi'an Jiaotong University 642
Large-scale testing (Phase 3)UnknownNCT00002477
What this trial is testing

Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Medical Research Council
Not applicableStudy completedNCT02707471
What this trial is testing

Improving Well-Being for Breast Cancer Patients

Who this might be right for
Self-management Intervention (SM-AET)General Health Education
Duke University 312
Not applicableStudy completedNCT04467593
What this trial is testing

Safety Study of Whole Body Hyperthermia for Advanced Cancer

Who this might be right for
Advanced CancerPancreatic Cancer Metastatic
ElmediX 16
Not applicableStudy completedNCT02936414
What this trial is testing

Berberine Effect on Cytokine, CRP, Metabolic Disturbance as an Adjunctive Therapy in Schizophrenia Patients

Who this might be right for
Schizophrenia
Tianjin Anding Hospital 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07005557
What this trial is testing

Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer

Who this might be right for
Breast CancerAdjuvant Therapy
Fudan University 1,244
Testing effectiveness (Phase 2)Study completedNCT02927301
What this trial is testing

Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 181
Early research (Phase 1)Ended earlyNCT01143545
What this trial is testing

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Who this might be right for
Lung CancerEsophageal CancerMalignant Pleural Mesothelioma+2 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Next Page